Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy
Author:
Affiliation:
1. Department of Gynecologic Oncology Saitama Medical University International Medical Center Saitama Japan
2. Department of Gynecology Hyogo Cancer Center Hyogo Japan
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32475
Reference21 articles.
1. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first‐line interventions;Karam A;Ann Oncol,2017
2. Long‐term results of dose‐dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open‐label trial;Katsumata N;Lancet Oncol,2013
3. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO‐7): a randomised, multicentre, open‐label, phase 3 trial;Pignata S;Lancet Oncol,2014
4. Weekly vs. every‐3‐week paclitaxel and carboplatin for ovarian cancer;Chan JK;N Engl J Med,2016
5. ICON8: a GCIG phase III randomised trial evaluating weekly dose‐dense chemotherapy integration in first‐line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression‐free survival (PFS) analysis [abstract 929O_PR];Clamp A;Ann Oncol,2017
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiomics in the evaluation of ovarian masses — a systematic review;Insights into Imaging;2023-10-02
2. A diagnosis of ovarian cyst using deep learning neural network with XGBoost algorithm;International Journal of Information Technology;2023-08-18
3. A systematic review and meta-analysis of CT and MRI radiomics in ovarian cancer: methodological issues and clinical utility;Insights into Imaging;2023-07-03
4. Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin;Cancers;2023-04-04
5. Long‐term risk of cancer among the first‐degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up;Acta Obstetricia et Gynecologica Scandinavica;2023-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3